Track topics on Twitter Track topics that are important to you
Replicor is a privately held biopharmaceutical company with the most advanced animal and human clinical data in the development of the cure for HBV and HDV. The company is dedicat...
REPLICor Inc. is a biopharmaceutical company developing novel broad-spectrum antiviral drugs. Its lead compound, REP 9, is active against 12 viral families including influenza, hepatitis B and C, HIV,...
REPLICor is focused on discovering and developing a technology based upon the biological mechanisms of the initiation of DNA replication. Notwithstanding its focus, the company has access to a broadly...
We have published hundreds of Replicor Inc. news stories on BioPortfolio along with dozens of Replicor Inc. Clinical Trials and PubMed Articles about Replicor Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Replicor Inc. Companies in our database. You can also find out about relevant Replicor Inc. Drugs and Medications on this site too.
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...